These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2408732

  • 1. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization.
    Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M.
    Cancer; 1985 Jul 15; 56(2):302-8. PubMed ID: 2408732
    [Abstract] [Full Text] [Related]

  • 2. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer.
    Kato H, Morioka H, Tsutsui H, Aramaki S, Torigoe T.
    Cancer; 1982 Oct 01; 50(7):1294-6. PubMed ID: 7104971
    [Abstract] [Full Text] [Related]

  • 3. Carcinoembryonic antigen in carcinoma of the uterine cervix: antigen distribution in primary and metastatic tumors.
    van Nagell JR, Hudson S, Gay EC, Donaldson ES, Hanson M, Powell DF, Goldenberg DM.
    Cancer; 1982 Jan 15; 49(2):379-83. PubMed ID: 6274508
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of tumor associated antigen TA-4 in gynecologic tumors].
    Inoue Y, Ueda G, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Nishino T, Saito J, Abe Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun 15; 37(6):919-22. PubMed ID: 3894536
    [Abstract] [Full Text] [Related]

  • 5. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY, Chang DY, Huang SC, Yen ML, Juang GT, Ouyang PC.
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug 15; 88(8):797-800. PubMed ID: 2592943
    [Abstract] [Full Text] [Related]

  • 6. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma.
    Senekjian EK, Young JM, Weiser PA, Spencer CE, Magic SE, Herbst AL.
    Am J Obstet Gynecol; 1987 Aug 15; 157(2):433-9. PubMed ID: 3475982
    [Abstract] [Full Text] [Related]

  • 7. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 15; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H, Nagaya T, Torigoe T.
    Gan; 1984 May 15; 75(5):433-5. PubMed ID: 6745563
    [Abstract] [Full Text] [Related]

  • 9. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G, Würz H, Bolte A.
    Geburtshilfe Frauenheilkd; 1987 Jul 15; 47(7):439-45. PubMed ID: 3623046
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
    Ueda G, Inoue Y, Yamasaki M, Inoue M, Tanaka Y, Hiramatsu K, Saito J, Nishino T, Abe Y.
    Int J Gynecol Pathol; 1984 Jul 15; 3(3):291-8. PubMed ID: 6389386
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneous distribution of acidic TA-4 in cervical squamous cell carcinoma: immunohistochemical demonstration with monoclonal antibodies.
    Kato H, Suehiro Y, Morioka H, Torigoe T, Myoga A, Sekiguchi K, Ikeda I.
    Jpn J Cancer Res; 1987 Nov 15; 78(11):1246-50. PubMed ID: 3121560
    [Abstract] [Full Text] [Related]

  • 12. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinomas of the uterine cervix.
    Crombach G, Scharl A, Vierbuchen M, Würz H, Bolte A.
    Cancer; 1989 Apr 01; 63(7):1337-42. PubMed ID: 2920361
    [Abstract] [Full Text] [Related]

  • 13. [Tumor antigen TA-4 of squamous cell carcinoma in patients with cervical cancer].
    Kato H, Morioka H, Aramaki S, Tamai K, Nagaya T, Nagai M, Torigoe T.
    Gan No Rinsho; 1984 May 01; 30(6 Suppl):574-7. PubMed ID: 6748228
    [Abstract] [Full Text] [Related]

  • 14. The Validity of Using Human Squamous Cell Carcinoma Associated Antigen and Cytokeratin 19 Fragment Antigen 21-1 to Predict Postoperative Adjuvant Radiotherapy for Nonbulky Early-Stage Squamous Cell Carcinoma of the Cervix.
    Liu CZ, Zeng HX, Zhao JJ, Rong Y, Mo ZL, Li LA, Zhang JQ.
    Int J Gynecol Cancer; 2017 Jun 01; 27(5):994-1000. PubMed ID: 28498239
    [Abstract] [Full Text] [Related]

  • 15. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs.
    Mino N, Iio A, Hamamoto K.
    Cancer; 1988 Aug 15; 62(4):730-4. PubMed ID: 2840187
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix.
    Kato H, Morioka H, Aramaki S, Tamai K, Torigoe T.
    Am J Obstet Gynecol; 1983 Feb 01; 145(3):350-4. PubMed ID: 6824024
    [Abstract] [Full Text] [Related]

  • 17. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma.
    Kato H, Tamai K, Morioka H, Nagai M, Nagaya T, Torigoe T.
    Cancer; 1984 Oct 15; 54(8):1544-6. PubMed ID: 6478396
    [Abstract] [Full Text] [Related]

  • 18. Tumor antigen of human cervical squamous cell carcinoma: correlation of circulating levels with disease progress.
    Kato H, Miyauchi F, Morioka H, Fujino T, Torigoe T.
    Cancer; 1979 Feb 15; 43(2):585-90. PubMed ID: 421183
    [Abstract] [Full Text] [Related]

  • 19. Serum level of squamous cell carcinoma antigen and tumor size are useful to identify preoperatively patients at high risk of cervical cancer.
    Chou CY, Wang ST, Kuo HC, Tzeng CC, Yao BL.
    Cancer; 1994 Nov 01; 74(9):2497-501. PubMed ID: 7923006
    [Abstract] [Full Text] [Related]

  • 20. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
    Oishi T, Maruo T, Yamasaki M, Mochizuki M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 May 01; 39(5):799-806. PubMed ID: 3598275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.